Inventor
Satyanarayana Kuchimanchi
Inventor
Acton, MA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes28%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07HSugars13%
Y02ATechnologies for adaptation to climate change7%
C07KPeptides3%
C12YEnzymes1%
PatentTitleYear
11,118,181Compositions and methods for inhibition of expression of protein C (PROC) genes202111,091,761Organic compositions to treat HSF1-related diseases202111,034,958Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof202110,814,007Angiotensinogen (AGT) iRNA compositions and methods of use thereof202010,668,170Modified RNAi agents202010,570,391RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases202010,407,679Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof201910,287,582Organic compositions to treat HSF1-related diseases201910,273,478Compositions and methods for inhibition of expression of protein C (PROC) genes201910,238,749Angiotensinogen (AGT) iRNA compositions and methods of use thereof201910,125,369PCSK9 iRNA compositions and methods of use thereof201810,023,862Organic compositions to treat beta-catenin-related diseases20189,970,006Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes20189,850,488Complement component C5 iRNA compositions and methods of use thereof20179,796,974'Modified RNAi agents'20179,725,718'Compositions and methods for inhibition of expression of protein C (PROC) genes'20179,701,963'Complement component C5 iRNA compositions and methods of use thereof'20179,540,643'Organic compositions to treat HSF1-related diseases'20179,399,775'RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases'20169,376,680'Serpinc1 iRNA compositions and methods of use thereof'20169,315,813'Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes'20169,249,415'Complement component C5 iRNA compositions and methods of use thereof'20169,228,188'Compositions and method for inhibiting hepcidin antimicrobial peptide (HAMP) or HAMP-related gene expression'20169,127,274'Serpinc1 iRNA compositions and methods of use thereof'20159,096,637'Organic compositions to treat HSF1-related diseases'20159,068,184'Compositions and methods for inhibition of expression of protein C (PROC) genes'20158,623,838'Organic compositions to treat HSF1-related diseases'20148,481,509'Organic compositions to treat HSF1-related diseases'20138,293,718'Organic compositions to treat HSF1-related diseases'2012Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2012–2018Patents assigned to KUCHIMANCHI SATYANARAYANA (7)· patent assignee history
2012–2018Patents assigned to MILSTEIN STUART (7)· patent assignee history
2012–2021Based in Cambridge, MA, US· patent location history
2015–2021Patents assigned to ALNYLAM PHARMACEUTICALS INC (21)· patent assignee history
2015–2018Patents assigned to BETTENCOURT BRIAN (4)· patent assignee history
2015Based in Weston, MA, US· patent location history
2016–2021Based in Acton, MA, US· patent location history
2017–2021Patents assigned to ARROWHEAD PHARMACEUTICALS INC (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 21 | 2015–2021 |
| KUCHIMANCHI SATYANARAYANAself | 7 | 2012–2018 |
| MILSTEIN STUART | 7 | 2012–2018 |
| ARROWHEAD PHARMACEUTICALS INC | 4 | 2017–2021 |
| BETTENCOURT BRIAN | 4 | 2015–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Acton, Massachusetts, US | 16 | 2016–2021 |
| Cambridge, Massachusetts, US | 12 | 2012–2021 |
| Weston, Massachusetts, US | 1 | 2015 |